Pathology and response review for a residual hypermetabolic focus after lymphoma treatment

A 39-year-old woman from Russia with diffuse large B-cell lymphoma had residual PET uptake after prior therapy.

Patient origin俄罗斯

Medical direction血液病与淋巴瘤

Core needClear diagnosis direction & hospital selection

Service stagesBefore, during, and after the trip

Medical background & core patient needs

A 39-year-old woman from Russia with diffuse large B-cell lymphoma had residual PET uptake after prior therapy. Existing information came from different institutions with inconsistent formats, dates and conclusions, so the clinical chronology and key evidence had to be rebuilt first.

The family wanted to clarify the hospital direction, additional tests needed, expected admission process and length of stay before departure — to make a better-prepared cross-border decision.

Four questions that needed answering first

Verify diagnostic evidence
Obtain a second opinion
Control time in China
Create a return-home plan

Decision challenges

What the patient really needed was more than contacting a hospital

Cross-border decisions must answer four questions at once: is the case suitable, is the hospital a match, are records complete, and how will the trip work.

Evidence completeness

Original imaging, pathology or longitudinal tests determine review quality.

Specialty sequencing

Tests and decisions create dependencies between departments.

Cross-border execution

Language, travel time and follow-up must be planned together.

Admission feasibility

Hospital criteria, expected duration and the patient's practical arrangements had to be confirmed together.

Full service pathway

Six continuous stages, from case review to follow-up at home

Each stage has a clear goal, deliverables and next steps, so patients and families always know how far the service has progressed.

Record intake

2026-02 · Files were classified, translated and checked for missing imaging or reports.

Expert pre-review

2026-03 · The summary was submitted to confirm specialty, required data and expected duration.

Care in China

2026-04 · Tests, consultations and joint review were sequenced by clinical dependency.

Follow-up at home

2026-05 · Formal documents were organized for handover to the local physician.

Core service value

Turning professional opinions into actionable next steps

A bilingual record index, key-question list and missing-item check were prepared. Relevant hematology teams were matched for remote pre-review before examinations, consultations, joint discussion and departure handover were sequenced.

Bilingual file preparation Specialty matching Appointment sequencing Written handover

Milestones achieved

Key questions confirmed, the path to China became clearer

Deliverables included a joint review framework for hematology, pathology, nuclear medicine and radiotherapy, a time-and-cost range, a formal-document checklist and post-return monitoring points. Formal hospital advice remains authoritative.

Clinical fact sheet

Symptoms, tests, treatments and changes organized chronologically.

Visit schedule

Examinations, appointments and joint reviews listed in order.

Follow-up pack

Formal documents, review dates and communication questions archived.

Action checklist

Preparation before travel, priorities in China and follow-up actions at home were clearly defined.

Your case can also start with one professional review

Submit your basic records and our team will explain hospital options, document requirements and next steps for your case.